Marine Antibiotics 2020
Funding
Conflicts of Interest
References
- Chu, L.; Huang, J.; Muhammad, M.; Deng, Z.; Gao, J. Genome Mining as a Biotechnological Tool for the Discovery of Novel Marine Natural Products. Crit. Rev. Biotechnol. 2020, 40, 571–589. [Google Scholar] [CrossRef] [PubMed]
- Dührkop, K.; Nothias, L.-F.; Fleischauer, M.; Reher, R.; Ludwig, M.; Hoffmann, M.A.; Petras, D.; Gerwick, W.H.; Rousu, J.; Dorrestein, P.C.; et al. Systematic Classification of Unknown Metabolites Using High-Resolution Fragmentation Mass Spectra. Nat. Biotechnol. 2021, 39, 462–471. [Google Scholar] [CrossRef]
- Overview: The Ongoing Threat of Antimicrobial Resistance—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/33011053/ (accessed on 10 June 2021).
- Desriac, F.; El Harras, A.; Simon, M.; Bondon, A.; Brillet, B.; Le Chevalier, P.; Pugnière, M.; Got, P.; Destoumieux-Garzón, D.; Fleury, Y. Alterins Produced by Oyster-Associated Pseudoalteromonas Are Antibacterial Cyclolipopeptides with LPS-Binding Activity. Mar. Drugs 2020, 18, 630. [Google Scholar] [CrossRef] [PubMed]
- Sabdaningsih, A.; Liu, Y.; Mettal, U.; Heep, J.; Riyanti; Wang, L.; Cristianawati, O.; Nuryadi, H.; Triandala Sibero, M.; Marner, M.; et al. A New Citrinin Derivative from the Indonesian Marine Sponge-Associated Fungus Penicillium citrinum. Mar. Drugs 2020, 18, 227. [Google Scholar] [CrossRef] [PubMed]
- García-Davis, S.; Leal-López, K.; Molina-Torres, C.A.; Vera-Cabrera, L.; Díaz-Marrero, A.R.; Fernández, J.J.; Carranza-Rosales, P.; Viveros-Valdez, E. Antimycobacterial Activity of Laurinterol and Aplysin from Laurencia johnstonii. Mar. Drugs 2020, 18, 287. [Google Scholar] [CrossRef] [PubMed]
- Benoist, L.; Houyvet, B.; Henry, J.; Corre, E.; Zanuttini, B.; Zatylny-Gaudin, C. In-Depth In Silico Search for Cuttlefish (Sepia officinalis) Antimicrobial Peptides Following Bacterial Challenge of Haemocytes. Mar. Drugs 2020, 18, 439. [Google Scholar] [CrossRef] [PubMed]
- Nweze, J.A.; Mbaoji, F.N.; Huang, G.; Li, Y.; Yang, L.; Zhang, Y.; Huang, S.; Pan, L.; Yang, D. Antibiotics Development and the Potentials of Marine-Derived Compounds to Stem the Tide of Multidrug-Resistant Pathogenic Bacteria, Fungi, and Protozoa. Mar. Drugs 2020, 18, 145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fleury, Y. Marine Antibiotics 2020. Mar. Drugs 2021, 19, 351. https://doi.org/10.3390/md19060351
Fleury Y. Marine Antibiotics 2020. Marine Drugs. 2021; 19(6):351. https://doi.org/10.3390/md19060351
Chicago/Turabian StyleFleury, Yannick. 2021. "Marine Antibiotics 2020" Marine Drugs 19, no. 6: 351. https://doi.org/10.3390/md19060351